Web Analytics

Investor Profile

Novartis

Novartis Switzerland - Basel, Baselstadt
INVESTOR

1 Disclosed Funding Rounds $223,000,000
5 Participating Investments




Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treat

Invested In

Company Date Round Raised
  Cleerly July, 25 ,2022 Series C $223,000,000
  Flare Therapeutics March, 23 ,2023 Series B $123,000,000
  RxLightning Inc. June, 07 ,2023 Series A $17,500,000
  Fore Biotherapeutics August, 25 ,2023 Series D $75,000,000
  Capstan Therapeutics March, 21 ,2024 Series B $175,000,000